Seguici su

Need to realign patient-oriented and commercial and academic research

The Lancet, 378 (9805): 1777-1778, 2011

An essential component of any new governance strategy would be to bring together all the stakeholders, starting from an analysis of existing and ongoing research, produced independently of vested interests. Patient advocacy groups in myeloma spend millions to support research, hoping to promote better care. With public support they should be in a strong position to call for  redefi nition of the research agenda, in the interests of patients. I hope this approach can be further debated in many other areas of clinical research in oncology and beyond.


Liberati A
Data di pubblicazione:
Tipo di pubblicazione:
articoli di rivista
Lingua della pubblicazione:
Scarica la pubblicazione:
download (PDF, 0.10 MB)

Azioni sul documento

pubblicato il 2011/11/01 01:00:00 GMT+2 ultima modifica 2019-01-11T11:18:35+02:00

Valuta il sito

Non hai trovato quello che cerchi ?

Piè di pagina